China adds second GLP-1 diabetes drug to essential medicine list
- Posted on July 9, 2026
- By Bing News
- 0 Views
- 1 min read
China adds second GLP-1 diabetes drug to essential medicine list
By Andrew Silver SHANGHAI, July 9 (Reuters) - China will add a second GLP-1 drug, used to treat diabetes, to a list of essential drugs all public hospitals are required to prioritise having in their formulary, a government statement said on Thursday. China, the world's second-biggest pharmaceutical market, has the highest number of adults with diabetes in the world, according to estimates from
